More than the sum: How vascular endothelial growth factor inhibition unlocks the full potential of immune checkpoint blockade

The combination of antiangiogenic and immune checkpoint inhibitor (ICI) treatment is active in solid tumors, but the mechanism of response remains unclear. In this issue of Immunity, Benmebarek et al. show that anti-vascular endothelial growth factor e…

Soluble CTLA-4 regulates immune homeostasis and promotes resolution of inflammation by suppressing type 1 but allowing type 2 immunity

CTLA-4 exists as membrane (mCTLA-4) and soluble (sCTLA-4) forms. Immunological roles of sCTLA-4 are scarcely known. With mice deficient in either sCTLA-4 or mCTLA-4, Osaki et al. show that sCTLA-4, which is predominantly produced by Treg cells, suppres…

deneme bonusu veren siteler - canlı bahis siteleri - casino siteleri casino siteleri deneme bonusu veren siteler canlı casino siteleri
news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news news